Page last updated: 2024-08-21

isoxazoles and Lymphoma, Mantle-Cell

isoxazoles has been researched along with Lymphoma, Mantle-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bararia, D; Bird, L; Christie, AL; Christodoulou, A; Haebe, S; Jacobson, C; Kopp, N; Layer, JV; Redd, RA; Rodig, SJ; Saur, A; Tivey, T; Tschuri, S; van Bodegom, D; Weigert, O; Weinstock, DM; Zapf, S; Zimber-Strobl, U1

Other Studies

1 other study(ies) available for isoxazoles and Lymphoma, Mantle-Cell

ArticleYear
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma.
    Blood, 2016, 11-24, Volume: 128, Issue:21

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Amino Acid Substitution; Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lymphoma, Mantle-Cell; Mice; Mutation, Missense; Piperidines; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Resorcinols; Xenograft Model Antitumor Assays

2016